(Q38018382)

27 August 2017

0 references

Hepatitis B virus infection increases the risk of cholangiocarcinoma: a meta-analysis and systematic review (English)

1 reference

27 August 2017

0 references

1 reference

1 reference

1 reference

1 reference

Min Li

1

1 reference

27 August 2017

Jinzheng Li

2

1 reference

27 August 2017

Peizhi Li

3

1 reference

27 August 2017

Hongyang Li

4

1 reference

27 August 2017

Tianyi Su

5

1 reference

27 August 2017

Rongtao Zhu

6

1 reference

27 August 2017

Jianping Gong

7

1 reference

27 August 2017

publication date

1 October 2012

1 reference

Journal of Gastroenterology and Hepatology

27 August 2017

published in

1 reference

27 August 2017

volume

27

1 reference

27 August 2017

issue

10

1 reference

27 August 2017

page(s)

1561-1568

1 reference

Cholangiocarcinoma--controversies and challenges

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Cholangiocarcinoma: lessons from Thailand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Cholangiocarcinoma: update and future perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

"Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Worldwide trends in mortality from biliary tract malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Molecular pathology of biliary tract cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Proliferating cholangiocytes: a neuroendocrine compartment in the diseased liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Epidemiology of cholangiocarcinoma: an update focusing on risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Cholangiocarcinoma: recent progress. Part 1: epidemiology and etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

The epidemiology of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Risk factors for cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Risk factors for intrahepatic cholangiocarcinoma: a possible role of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Hepatitis B and C virus infection and the risk of biliary tract cancer: a population-based study in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Risk factors for hilar cholangiocarcinoma: a case-control study in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Increasing incidence of intrahepatic cholangiocarcinoma and its relationship to chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Expression and significance of HBV genes and their antigens in human primary intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Hepatitis B virus and intrahepatic cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Activation-induced cytidine deaminase links bile duct inflammation to human cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Epithelial-mesenchymal transition induced by hepatitis C virus core protein in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.2012.07207.X

10.1111/J.1440-1746.2012.07207.X

21 January 2018

Identifiers

DOI

1 reference

27 August 2017

1 reference